IBDEI0GK ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^1394^1394
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=ADJUSTMENT DISORDERS^2^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=ANXIETY DISORDERS^4^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=AMNESTICS^3^1
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=ORGANIC DISORDERS^11^1
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=DEMENTIA^7^1
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=DELIRIUM^6^1
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=BIPOLAR DISORDERS^5^1
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=PSYCHOSIS^14^1
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=PERSONALITY DISORDERS^13^1
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=SEXUAL DISORDERS^16^1
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=SLEEP DISORDERS^17^1
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=OTHER DISORDERS^21^1
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=SUBSTANCE RELATED DISORDERS^1^1
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=V CODES^19^1
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=PREVENTION/COUNSELING/SCREEN^20^1
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=DEPRESSION^8^1
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=MOOD DISORDERS (OTHER)^10^1
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=SCHIZOPHRENIA^15^1
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=SOMATIFORM DISORDERS^18^1
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=EATING DISORDERS^9^1
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=SUBSTANCE ABUSE^4^2
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=DIAGNOSTIC EVALUATION^1^2
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=PSYCHOTHERAPY ^2^2
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=OTHER CODES^3^2
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=OTHER COMMUNITY ADHC DX^2^3
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=ADHC^1^3
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=CASE MANAGEMENT VISIT^1^4
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=ESTABLISHED PATIENT^2^4
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=CARE PLAN OVERSIGHT^3^4
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=CARE PLAN OVERSIGHT^1^5
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=OTHER SERVICES^2^5
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=PRE-OP VISIT-CLINICIAN^1^6
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=CONSULTATION-CLINICIAN^2^6
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=POST-OP VISIT^3^6
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=NERVE BLOCK^12^7
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=CATH^2^7
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=CVA DEVICE^3^7
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=EPIDURAL^4^7
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=FOREARM/WRIST/HAND^5^7
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=HEAD^6^7
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=INTRATHORACIC^7^7
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=IV^8^7
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=LOWER ABDOMEN^9^7
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=LOWER LEG^10^7
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=NECK^11^7
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=ARTERIAL^1^7
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=OTHER^13^7
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=PELVIS^14^7
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=RADIOLOGICAL PROCEDURE^15^7
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=SHOULDER/AXILLA^16^7
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=SPINAL NERVES^17^7
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=SPINE/SPINAL CORD^18^7
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=TEE^19^7
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=THORAX^20^7
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=UPPER ABDOMEN^21^7
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=UPPER ARM/ELBOW^22^7
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=UPPER LEG^23^7
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=ABDOMINAL PAIN^1^8
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=PRE/POST SURGERY^9^8
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=GENERAL/SIGNS & SYMPTOMS^5^8
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=MALIGNANT NEOPLASMS^7^8
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=DISEASES OF NERVOUS SYSTEM^4^8
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=OTHER^8^8
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=RESPIRATORY^10^8
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=CARDIAC^2^8
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=DISEASES OF DIGESTIVE SYSTEM^3^8
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=INFECTIOUS DISEASES^6^8
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=ESTABLISHED PATIENT^2^9
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=EAR DISEASES^1^10
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=FACTOR INFLUENCING HEALTH^2^10
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=HEARING LOSS (HL)^3^10
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=OTHER^5^10
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=NYSTAGMUS^4^10
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=AUDIOLOGIC FUNCTION TESTS^1^11
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=SCREENING^7^11
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=OTHER^10^11
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=COCHLEAR IMPLANT^2^11
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=OTHER TREATMENT^11^11
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=DISPENSING^4^11
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=REMOVAL FOREIGN BODY/CERUMEN^6^11
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=VESTIBULAR FUNCTION TESTS W/ RECORDING^9^11
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=VESTIBULA FUNCTION W/O RECORDING^8^11
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=HA ORIENTATION^5^11
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=DEVICE CODES ^3^11
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=TYPE OF VISIT^1^12
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=CONTRIBUTORY CONDITION^2^13
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=IMPAIRMENT CODES-COND TREATED^1^13
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=TBI-RELATED CONTRIB COND^3^13
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=PRIMARY DX (REASON FOR VISIT)^1^14
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=ASSESSMENT/COUNSELING^1^15
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=ONE ON ONE TRAINING^8^15
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=GROUP/FAMILY TRAINING^6^15
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=TEAM CONFERENCE^10^15
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=SECONDARY PROCEDURE ONLY (MISC.)^9^15
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=HOME VISIT^7^15
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=FUNCTIONAL REPORTING MOBILITY^4^15
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=FUNCTIONAL REPORTING BODY POSITION^2^15
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=FUNCTIONAL REPORTING CARRY OBJECTS^3^15
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=FUNCTIONAL REPORTING SELF CARE^5^15
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=MYOCARDIAL INFARCTION^11^16
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=CHF / MYOPATHY / TRANSPLANT^3^16
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=ARRHYTHMIA^1^16
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=PERIPHERAL VASC DIS^16^16
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=INFECT/INFLAM DISEASE^9^16
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=SYNCOPE/HYPOTENSION^19^16
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=GENERAL SYMPTOMS^6^16
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=LIPID DISORDERS^10^16
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=SCREENING^18^16
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=CHEST PAIN^2^16
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=CORONARY ATHEROSCLEROSIS^5^16
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=OTHER FORMS OF HEART DISEASE^14^16
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=HYPERTENSION^8^16
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=NONRHEUMATIC HEART VALVE DISEASE^12^16
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=RHEUMATIC HEART DISEASE^17^16
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=COMPLICATIONS^4^16
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=HISTORY CODES^7^16
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=OTHER CONDITIONS^13^16
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=PACEMAKER^7^17
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=CORONARY ANGIOPLASTY & STENTS^2^17
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=ELECTROPHYSIOLOGICAL PROCs^3^17
 ;;^UTILITY(U,$J,358.4,121,0)
 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^8^17
 ;;^UTILITY(U,$J,358.4,122,0)
 ;;=VASCULAR INJECTION PROCs^10^17
 ;;^UTILITY(U,$J,358.4,123,0)
 ;;=OTHER PROCEDURES^6^17
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=HEART CATHETERIZATIONS^4^17
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^1^17
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=OTHER HEART CODES/ECHO^5^17
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^9^17
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=EKG^3^18
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=OTHER CARDIAC^6^18
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=ECHO^2^18
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=STRESS TESTS^7^18
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=DEVICE PROGRAMMING^1^18
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=MEDICATION ADMINISTRATION^4^18
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=MEDICATIONS^5^18
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=NEW PATIENT^2^19
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=ESTABLISHED PATIENT^1^19
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=CONSULTATIONS^3^19
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=MYOCARDIAL INFARCTION^11^20
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=CHF / MYOPATHY / TRANSPLANT^3^20
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=ARRHYTHMIA^1^20
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=PERIPHERAL VASC DIS^16^20
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=INFECT/INFLAM DISEASE^9^20
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=SYNCOPE/HYPOTENSION^19^20
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=GENERAL SYMPTOMS^6^20
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=LIPID DISORDERS^10^20
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=SCREENING^18^20
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=CHEST PAIN^2^20
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=CORONARY ATHEROSCLEROSIS^5^20
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=OTHER FORMS OF HEART DISEASE^14^20
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=HYPERTENSION^8^20
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=NONRHEUMATIC HEART VALVE DISEASE^12^20
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=RHEUMATIC HEART DISEASE^17^20
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=COMPLICATIONS^4^20
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=HISTORY CODES^7^20
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=OTHER CONDITIONS^13^20
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=SPECIAL SERVICES^6^21
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=CHEMO NURSE PROCEDURES^2^21
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=INFUSION DRUGS^4^21
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=BLOOD PRODUCTS^1^21
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=DIAGNOSTIC PROCEDURES^3^21
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=OTHER DRUGS^5^21
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=NEW PATIENT^2^22
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=ESTABLISHED PATIENT^1^22
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=CONSULTATIONS^3^22
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=ANEMIA^1^23
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=COAGULATION DISORDERS^4^23
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^12^23
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=LYMPHOID NEOPLASMS^9^23
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=GI CANCER^7^23
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^23
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=MISC. NEOPLASMS^11^23
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=METASTATIC SITES^10^23
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=COUNSELING & SCREENING^5^23
